康亚药业 (872320.OC)

+ 收藏

利润表(康亚药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2023年一季报2022年年报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 153,788,241.7865,877,345.8824,338,455.50166,335,503.1650,601,932.8215,487,242.44
 营业收入(元) 153,788,241.7865,877,345.8824,338,455.50166,335,503.1650,601,932.8215,487,242.44
二、营业总成本(元) 146,491,580.5266,391,266.9427,403,417.28127,009,267.2051,028,890.6920,041,678.83
 营业成本(元) 53,756,403.8424,735,804.4810,167,409.1044,660,105.7417,072,248.436,534,396.55
 研发费用(元) 32,987,318.7816,737,241.765,677,564.8121,578,817.059,625,108.464,108,457.32
 营业税金及附加(元) 2,663,069.091,078,810.97447,310.212,369,733.20986,074.12425,914.14
 销售费用(元) 29,916,178.3015,183,733.706,591,972.7542,686,554.9015,955,054.336,015,097.52
 管理费用(元) 26,060,878.128,272,114.464,340,598.8014,365,942.126,672,884.812,853,220.43
 财务费用(元) 1,107,732.39383,561.57178,561.611,348,114.19717,520.54104,592.87
  其中:利息费用(元) 1,409,740.36589,033.53294,716.221,538,444.97885,244.79222,764.02
  其中:利息收入(元) 219,433.36229,837.39134,907.09207,596.82-180,779.82127,744.80
三、其他经营收益
 加:公允价值变动收益(元) ----552.54--
 加:投资收益(元) 2,567,546.051,234,554.67528,753.683,110,722.62729,256.01206,420.14
 资产处置收益(元) 62,110.627,095.72--1,410.38--
 资产减值损失(元) -1,853,030.79-1,074,457.81-129,427.92-891,464.24-160,743.85-
 信用减值损失(元) -506,826.99622,963.571,455,086.33-1,945,772.93149,407.28442,819.73
 其他收益(元) 15,573,112.774,800,257.621,900,398.484,712,506.881,816,256.03451,152.58
四、营业利润(元) 23,139,572.925,076,492.71689,848.7944,310,265.372,107,217.60-3,454,043.94
 加:营业外收入(元) 291,974.369,310.4831.1312,046.24241.07241.13
 减:营业外支出(元) 161,727.98107,054.9231,706.11262,697.5146,337.4663,851.35
五、利润总额(元) 23,269,819.304,978,748.27658,173.8144,059,614.102,061,121.21-3,517,654.16
 减:所得税费用(元) -914,442.00-973,564.19224,304.831,399,430.95-396,301.30-554,756.24
六、净利润(元) 24,184,261.305,952,312.46433,868.9842,660,183.152,457,422.51-2,962,897.92
(一)按经营持续性分类
  持续经营净利润(元) 24,184,261.305,952,312.46433,868.9842,660,183.15--2,962,897.92
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 23,515,900.725,772,740.41457,613.4041,799,047.142,465,842.92-2,940,941.66
  少数股东损益(元) 668,360.58179,572.05-23,744.42861,136.01-8,420.41-21,956.26
 扣除非经常性损益后的净利润(元) 20,499,556.321,893,846.05-1,559,241.0937,109,966.58833,111.86-
七、每股收益
 一、基本每股收益(元) 0.370.090.010.650.04-0.02
 二、稀释每股收益(元) ---0.650.04-
九、综合收益总额(元) 24,184,261.305,952,312.46433,868.9842,660,183.152,457,422.51-2,962,897.92
 归属于母公司所有者的综合收益总额(元) 23,515,900.725,772,740.41457,613.4041,799,047.142,465,842.92-2,940,941.66
 归属于少数股东的综合收益总额(元) 668,360.58179,572.05-23,744.42861,136.01-8,420.41-21,956.26
公告日期 2024-04-292023-08-302023-06-072023-04-272022-08-242023-06-07
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院